We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Announcements.
- Abstract
The article presents news briefs related to breast cancer. Genzyme Corp. and Bayer HealthCare Pharmaceuticals Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental biologics license application for alemtuzumab (Campath). Merck & Co. has announced a donation of 3 million doses of quadrivalent human papillomavirus recombinant vaccine. Progen Pharmaceuticals Ltd. has said that its anticancer drug PI-88 has been awarded fast track status by the U.S. FDA.
- Subjects
BREAST cancer; GENZYME Corp.; BAYER HealthCare Pharmaceuticals Inc.; UNITED States. Food &; Drug Administration; LICENSE agreements; MERCK &; Co. Inc.; HUMAN papillomavirus vaccines; PROGEN Pharmaceuticals Ltd.
- Publication
Oncology (08909091), 2007, Vol 21, Issue 11, p1322
- ISSN
0890-9091
- Publication type
Article